- ICH GCP
- US Clinical Trials Registry
- Researchers
- Turkey
- Macular Degeneration
Medical specialists from Turkey tagged as investigators in clinical trials studying Macular Degeneration
Total 17 results
-
Aslı ÇETİNKAYA YAPRAK, LecturerSeen in:
- Antalya, Akdeniz University Hospital
Trials:- NCT06213896 (Sub-Investigator)
-
Banu OZTURK, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Berkant KADERLI, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Esra AYHAN TUZCU, Assoc. Dr.Seen in:
- Antalya, Akdeniz University Hospital
Trials:- NCT06213896 (Sub-Investigator)
-
Handan YILDIZUS, PhDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Hurkan KERIMOGLU, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Mehmet BULUT, Assoc. Dr.Seen in:
- Antalya, Akdeniz University Hospital
Trials:- NCT06213896 (Sub-Investigator)
-
Mehmet Erkan DOĞAN, LecturerSeen in:
- Antalya, Akdeniz University Hospital
Trials:- NCT06213896 (Sub-Investigator)
-
Mujgan OZDEMIR, PhDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Mustafa DOGAN, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Mustafa ÜNAL, Prof. Dr.Seen in:
- Antalya, Akdeniz University Hospital
Trials:- NCT06213896 (Principal Investigator)
-
Nilufer KOCAK, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Ozgur YALCINBAYIR, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Remzi AVCI, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Suleyman DUNDAR, PhDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Suleyman KAYNAK, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions: -
Umit U INAN, MDSeen in:
- Afyon, Afyonkarahisar, Umit Ubeyt INAN
Trials:- NCT02248324 (Principal Investigator)
Conditions:
Clinical Trials on Macular Degeneration
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationChina
-
Hoffmann-La RocheWithdrawnNeovascular Age-Related Macular DegenerationDenmark, Argentina, Hong Kong, Thailand, Portugal, Greece, Spain
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
Novartis PharmaceuticalsTerminatedNeovascular Age-Related Macular Degeneration
-
Regeneron PharmaceuticalsCompletedNeovascular Age Related Macular DegenerationUnited States
-
Hoffmann-La RocheRecruitingNeovascular Age Related Macular Degeneration | nAMDChina
-
Centre Hospitalier Intercommunal CreteilCompletedMacular Degeneration Exudative Eye Left | Macular Degeneration Exudative Eye RightFrance
-
University of Modena and Reggio EmiliaCompletedMacular Degeneration Advanced | Macular Degeneration, Dry | Macular Degeneration, Senile | Macular Scar | Macular Degeneration NonexudativeItaly
-
Shanghai Refreshgene Technology Co., Ltd.RecruitingNeovascular Age-related Macular DegenerationChina
-
PharmAbcineC&R Research, Inc.RecruitingNeovascular Age-related Macular DegenerationKorea, Republic of